FGF4 and diabetes mellitus: In summary, our study demonstrates that podocyte-derived FGF4 activates the FGFR1-AMPK-FOXO1 signaling pathway to mitigate oxidative stress and promote podocyte survival, thereby preserving glomerular integrity and protecting the kidney from diabetes-induced injury.